A LEADING ORPHAN DRUG COMBINATION
Ergomed and PSR Orphan Experts have joined forces, creating an industry-leading rare disease CRO offering. Ergomed’s global reach and PSR’s specialized focus on orphan drug development will enable the improvement of lives of patients and families impacted by rare diseases across the world. For more information please click here https://mailchi.mp/90bc68c40b02/a-leading-orphan-drug-combination-1354505